NMLSF
Price:
$0.0622
Market Cap:
$3.61M
Restart Life Sciences Corp. is a biotechnology company, which engages in the research and development of psilocybin. It offers therapy and diagnostics for neuroinflammatory disorders. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
Industry
Biotechnology
IPO Date
2008-06-27
Stock Exchange
OTC
Ticker
NMLSF
According to Restart Life Sciences Corp.’s latest financial reports and current stock price. The company's current ROE is 404.52%. This represents a change of -327.64% compared to the average of -177.70% of the last 4 quarters.
The mean historical ROE of Restart Life Sciences Corp. over the last ten years is -1134.87%. The current 404.52% ROE has changed -135.64% with respect to the historical average. Over the past ten years (40 quarters), NMLSF's ROE was at its highest in in the September 2015 quarter at 1.08%. The ROE was at its lowest in in the December 2022 quarter at -5989.83%.
Average
-1134.87%
Median
-196.37%
Minimum
-9096.56%
Maximum
151.05%
Discovering the peaks and valleys of Restart Life Sciences Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.14%
Maximum Annual ROE = 151.05%
Minimum Annual Increase = -149.75%
Minimum Annual ROE = -9096.56%
| Year | ROE | Change |
|---|---|---|
| 2024 | -75.15% | -149.75% |
| 2023 | 151.05% | -101.66% |
| 2022 | -9096.56% | 1.46% |
| 2021 | -584.75% | -38.27% |
| 2020 | -947.35% | 4.14% |
| 2019 | -22.33% | -54.73% |
| 2018 | -49.34% | -18.93% |
| 2017 | -60.86% | -80.84% |
| 2016 | -317.59% | -8.16% |
| 2015 | -345.80% | -78.73% |
The current ROE of Restart Life Sciences Corp. (NMLSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3006.89%
5-year avg
-2110.55%
10-year avg
-1134.87%
Restart Life Sciences Corp.’s ROE is greater than Algernon Pharmaceuticals Inc. (-98.85%), less than Appili Therapeutics Inc. (16.72%), less than Ayala Pharmaceuticals, Inc. (12.17%), greater than Universal Ibogaine Inc. (-304.82%), greater than ReNeuron Group plc (-72.37%), less than Regen BioPharma, Inc. (17.33%), less than Agentix Corp. (135.68%), greater than VG Life Sciences Inc. (0%), less than America Great Health (20.07%), greater than Health Sciences Group, Inc. (2.53%),
| Company | ROE | Market cap |
|---|---|---|
| -98.85% | $1.92M | |
| 16.72% | $1.82M | |
| 12.17% | $4.41M | |
| -304.82% | $2.06M | |
| -72.37% | $62.89K | |
| 17.33% | $315.55K | |
| 135.68% | $1.71M | |
| 0% | $2.11M | |
| 20.07% | $2.12M | |
| 2.53% | $187.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Restart Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Restart Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Restart Life Sciences Corp.'s ROE?
How is the ROE calculated for Restart Life Sciences Corp. (NMLSF)?
What is the highest ROE for Restart Life Sciences Corp. (NMLSF)?
What is the 3-year average ROE for Restart Life Sciences Corp. (NMLSF)?
What is the 5-year average ROE for Restart Life Sciences Corp. (NMLSF)?
How does the current ROE for Restart Life Sciences Corp. (NMLSF) compare to its historical average?